Clinical Trial Update: Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating vincristine sulfate liposome for injection in adults with previously untreated acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Vincristine sulfate liposome injection (vincristine sulfate liposome injection)

Snippet

Sponsor: Nanjing Luye Sike Pharmaceutical Co., Ltd. | Conditions: Adult Acute Lymphoblastic Leukemia | Phase 3 | Status: UNKNOWN